Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,520.36
(
0.02%
)
US TECH 100
29,184.47
(
-0.09%
)
Dow Jones
50,644.28
(
0.36%
)
Brent Oil
92.44
(
-4.69%
)
Bitcoin
74,885.15
(
-1.27%
)
News Focus
News Focus
Post# of 257648
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: DewDiligence post# 155412

Tuesday, 01/15/2013 2:41:11 PM

Tuesday, January 15, 2013 2:41:11 PM

Post# of 257648
PDL BioPharma (PDLI -5.3%) slips after Credit Suisse cut the shares to Neutral on valuation and lowers its price target from $6.50 to $6.00. The firm adds that PDLI lacks significant optionality as new products deliver a finite and relatively short revenue stream.

Dew, are you familiar with PDLI ?..decent divi
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Unleash the power of Level 2

Spot liquidity moves with access to US order books.

Sign Up